COVID-19 Impact on Self-monitoring Blood Glucose Devices Market, Global Research Reports 2020-2021
Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.
The classification of self-monitoring blood glucose (SMBG) devices includes strips, glucose meter and lancet. The revenue proportion of strips in 2017 is about 85.08%, and the proportion is in increasing trend from 2013 to 2017.
This report provides a complete quantitative data and qualitative analysis on the global market for Self-monitoring Blood Glucose Devices. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Self-monitoring Blood Glucose Devices was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Self-monitoring Blood Glucose Devices is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Self-monitoring Blood Glucose Devices, including the following market information:
Global Self-monitoring Blood Glucose Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Self-monitoring Blood Glucose Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Self-monitoring Blood Glucose Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Self-monitoring Blood Glucose Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Roche Roche Diagnostics, Lifescan, Abbott Laboratories, Terumo, Ascensia (Bayer), etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Strips
Glucose Meter
Lancet
Other
Based on the Application:
Public Hospital
Private Hospital
Clinics
Pharmacy Shops
The classification of self-monitoring blood glucose (SMBG) devices includes strips, glucose meter and lancet. The revenue proportion of strips in 2017 is about 85.08%, and the proportion is in increasing trend from 2013 to 2017.
This report provides a complete quantitative data and qualitative analysis on the global market for Self-monitoring Blood Glucose Devices. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Self-monitoring Blood Glucose Devices was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Self-monitoring Blood Glucose Devices is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Self-monitoring Blood Glucose Devices, including the following market information:
Global Self-monitoring Blood Glucose Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Self-monitoring Blood Glucose Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Self-monitoring Blood Glucose Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Self-monitoring Blood Glucose Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Roche Roche Diagnostics, Lifescan, Abbott Laboratories, Terumo, Ascensia (Bayer), etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Strips
Glucose Meter
Lancet
Other
Based on the Application:
Public Hospital
Private Hospital
Clinics
Pharmacy Shops
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
